INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
XS

Xu Shanshan

Director, See remarks, 10% OwnerCIK 0002160743

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
147.2K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Bambusa Therapeutics, Inc.Director, See remarks, 10% Owner · Nov 2, 2026
9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C
—
4,155 sh
Nov 2, 2026
Nov 2, 2026
traded Nov 2, 2026
+0d
SEC FORM 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
10.4K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1,753 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
37.4K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
94.0K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
15.8K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Grant or award
A—
379.1K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Grant or award
A—
758.2K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
16.4K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence